New PET scan agent for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new imaging agent called 68Ga-AAZTA-NI-093 for a special PET/CT scan that might help see prostate cancer more clearly. It is for people with prostate cancer, whether they've had treatment or not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer (either treated or untreated).
- You are willing and able to sign a consent form.
- You do not have a known allergy to PSMA (a substance used in the scan).
- You don't have any other medical condition that might make it hard to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging method (GRPR PET) to help better see and stage prostate cancer. If you have prostate cancer, this scan may give doctors more detail about where the cancer is located.
This trial uses a special imaging test (PET/MRI) to look at prostate cancer in detail before surgery. The goal is to see if this imaging can help choose the best treatment, possibly sparing healthy tissue.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
This trial tests a new PET scan called XACP3 to see if it can find prostate cancer as well as the standard PSMA PET scan. You could help by having both scans to compare them.
This trial is testing a new type of PET scan that uses a special tracer called 68Ga-PSMA-CYC to take detailed pictures of prostate cancer. It may help doctors better see where the cancer is and how far it has spread.
This study tests a new imaging agent (68Ga-NYM032) used with PET/CT scans to help doctors better detect prostate cancer before surgery. If you have biopsy-confirmed prostate cancer and are planning to have your prostate removed, this trial may help evaluate whether this new imaging method improves cancer detection.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.